Garden State Investment Advisory Services’s AbbVie ABBV Stock Holding History

Garden State Investment Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$633K	Sell	2,515 -199	-7%	-$42.8K	0.11%	152
2026 Q1	$592K	Buy	2,714 +2	+0.1%	+$444	0.13%	134
2025 Q4	$621K	Sell	2,712 -7	-0.3%	-$1.59K	0.14%	128
2025 Q3	$629K	Sell	2,719 -341	-11%	-$69.4K	0.14%	121
2025 Q2	$569K	Sell	3,060 -115	-4%	-$21.4K	0.14%	130
2025 Q1	$667K	Sell	3,175 -141	-4%	-$27.4K	0.21%	92
2024 Q4	$591K	Buy	3,316 +36	+1%	+$6.62K	0.18%	103
2024 Q3	$649K	Sell	3,280 -46	-1%	-$8.59K	0.21%	94
2024 Q2	$572K	Buy	3,326 +5	+0.2%	+$828	0.2%	97
2024 Q1	$603K	Buy	3,321 +68	+2%	+$11.7K	0.22%	97
2023 Q4	$504K	Buy	3,253 +142	+5%	+$20.7K	0.2%	104
2023 Q3	$464K	Buy	3,111 +73	+2%	+$10.7K	0.21%	98
2023 Q2	$409K	Sell	3,038 -160	-5%	-$23.5K	0.16%	112
2023 Q1	$510K	Sell	3,198 -62	-2%	-$9.48K	0.22%	87
2022 Q4	$527K	Buy	+3,260	New	+$500K	0.31%	70

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garden State Investment Advisory Services's ABBV Position: Q2 2026 in Review

Garden State Investment Advisory Services reduced its AbbVie (ABBV) stake by 7.3% in Q2 2026, selling an estimated $42.8K and leaving 2,515 shares worth $633K. The position accounts for 0.11% of the portfolio, ranked #152.

Garden State Investment Advisory Services first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $667K in Q1 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Garden State Investment Advisory Services held 2,515 shares of AbbVie worth $633K as of Q2 2026.
Garden State Investment Advisory Services sold 199 AbbVie shares in Q2 2026, an estimated $42.8K.
AbbVie made up 0.11% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #152 holding.
Garden State Investment Advisory Services first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Garden State Investment Advisory Services's AbbVie position peaked at $667K in Q1 2025.
4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.